Peter Dragovich PhD

Pete Dragovich, Ph.D. worked in the pharmaceutical industry for more than 20 years at both large and small organizations. Much of Dragovich early career was spent discovering novel antiviral agents for the treatment of HIV, HCV, and respiratory illnesses. Since coming to Genentech in 2010, Dragovich has contributed to multiple discovery-stage projects that span a variety of different therapeutic areas. Dragovich Genentech's research includes studies in immunology, cancer metabolism, epigenetics, and (most recently) antibody-drug conjugates. Dragovich greatly enjoys the diversity of the science conducted at Genentech and has learned many new things since joining the organization.